Catalyst Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of CPRX for the last quarter is 110.57 M USD, and it's 7.67% higher compared to the previous quarter. The net income of Q4 23 is 34.84 M USD.